HRP20110749T1 - Kombinacija agomelatina sa sredstvom za stabiliziranje raspoloženja i farmaceutski pripravci koji ga sadržavaju - Google Patents
Kombinacija agomelatina sa sredstvom za stabiliziranje raspoloženja i farmaceutski pripravci koji ga sadržavaju Download PDFInfo
- Publication number
- HRP20110749T1 HRP20110749T1 HR20110749T HRP20110749T HRP20110749T1 HR P20110749 T1 HRP20110749 T1 HR P20110749T1 HR 20110749 T HR20110749 T HR 20110749T HR P20110749 T HRP20110749 T HR P20110749T HR P20110749 T1 HRP20110749 T1 HR P20110749T1
- Authority
- HR
- Croatia
- Prior art keywords
- agomelatine
- association
- pharmaceutical compositions
- combination
- disorder
- Prior art date
Links
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title claims abstract 4
- 229960002629 agomelatine Drugs 0.000 title claims abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004050 mood stabilizer Substances 0.000 title 1
- 229940127237 mood stabilizer Drugs 0.000 title 1
- 239000002253 acid Substances 0.000 claims abstract 3
- 239000003795 chemical substances by application Substances 0.000 claims abstract 3
- 208000026725 cyclothymic disease Diseases 0.000 claims abstract 3
- 208000024732 dysthymic disease Diseases 0.000 claims abstract 3
- 150000004677 hydrates Chemical class 0.000 claims abstract 3
- 230000001105 regulatory effect Effects 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 210000001541 thymus gland Anatomy 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/08—Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0509208A FR2890563B1 (fr) | 2005-09-09 | 2005-09-09 | Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20110749T1 true HRP20110749T1 (hr) | 2011-11-30 |
Family
ID=36190792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20110749T HRP20110749T1 (hr) | 2005-09-09 | 2011-10-14 | Kombinacija agomelatina sa sredstvom za stabiliziranje raspoloženja i farmaceutski pripravci koji ga sadržavaju |
Country Status (38)
Country | Link |
---|---|
US (1) | US7902180B2 (de) |
EP (2) | EP2301527A1 (de) |
JP (1) | JP2007077149A (de) |
KR (2) | KR20070029607A (de) |
CN (1) | CN1927194A (de) |
AP (1) | AP3045A (de) |
AR (1) | AR055418A1 (de) |
AT (1) | ATE519482T1 (de) |
AU (1) | AU2006209371B2 (de) |
BR (1) | BRPI0603767A (de) |
CA (1) | CA2558764C (de) |
CY (1) | CY1112223T1 (de) |
DK (1) | DK1762238T3 (de) |
EA (1) | EA014381B1 (de) |
ES (1) | ES2371482T3 (de) |
FR (1) | FR2890563B1 (de) |
GE (1) | GEP20094741B (de) |
GT (1) | GT200600410A (de) |
HR (1) | HRP20110749T1 (de) |
JO (1) | JO2746B1 (de) |
MA (1) | MA28504B1 (de) |
ME (1) | ME01964B (de) |
MX (1) | MXPA06010234A (de) |
MY (1) | MY162318A (de) |
NO (1) | NO338079B1 (de) |
NZ (1) | NZ549727A (de) |
PE (1) | PE20070613A1 (de) |
PL (1) | PL1762238T3 (de) |
PT (1) | PT1762238E (de) |
RS (1) | RS52003B (de) |
SA (1) | SA110320045B1 (de) |
SG (1) | SG131029A1 (de) |
SI (1) | SI1762238T1 (de) |
TW (1) | TWI369980B (de) |
UA (1) | UA83541C2 (de) |
UY (1) | UY29776A1 (de) |
WO (1) | WO2007028903A1 (de) |
ZA (1) | ZA200607532B (de) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (fr) | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
CZ20013786A3 (cs) * | 1999-04-29 | 2002-02-13 | Merck Patent Gmbh | Inhibitory glycinového ątěpicího systému jako moľná antipsychotika |
EP1600168A3 (de) * | 1999-12-01 | 2009-09-23 | Ucb, S.A. | Pyrrolidinacetamid-Derivat, allein oder kombiniert, zur Behandlung von ZNS-Störungen |
AR047553A1 (es) * | 2003-07-04 | 2006-01-25 | Lundbeck & Co As H | La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina |
FR2884714B1 (fr) * | 2005-04-20 | 2011-05-06 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires |
-
2005
- 2005-09-09 FR FR0509208A patent/FR2890563B1/fr not_active Expired - Fee Related
-
2006
- 2006-08-22 MA MA29280A patent/MA28504B1/fr unknown
- 2006-08-29 CN CNA2006101265895A patent/CN1927194A/zh active Pending
- 2006-08-31 UY UY29776A patent/UY29776A1/es not_active Application Discontinuation
- 2006-08-31 SG SG200605972-9A patent/SG131029A1/en unknown
- 2006-09-04 PE PE2006001069A patent/PE20070613A1/es not_active Application Discontinuation
- 2006-09-06 SA SA110320045A patent/SA110320045B1/ar unknown
- 2006-09-07 JO JO2006303A patent/JO2746B1/en active
- 2006-09-07 GE GEAP20069610A patent/GEP20094741B/en unknown
- 2006-09-07 NZ NZ549727A patent/NZ549727A/en not_active IP Right Cessation
- 2006-09-07 MY MYPI20064103A patent/MY162318A/en unknown
- 2006-09-07 US US11/516,992 patent/US7902180B2/en not_active Expired - Fee Related
- 2006-09-08 AR ARP060103909A patent/AR055418A1/es not_active Application Discontinuation
- 2006-09-08 ME MEP-2011-407A patent/ME01964B/de unknown
- 2006-09-08 EP EP10011609A patent/EP2301527A1/de not_active Withdrawn
- 2006-09-08 EA EA200601450A patent/EA014381B1/ru not_active IP Right Cessation
- 2006-09-08 UA UAA200609685A patent/UA83541C2/uk unknown
- 2006-09-08 EP EP06291423A patent/EP1762238B1/de active Active
- 2006-09-08 WO PCT/FR2006/002066 patent/WO2007028903A1/fr active Application Filing
- 2006-09-08 ZA ZA2006/07532A patent/ZA200607532B/en unknown
- 2006-09-08 AP AP2008004380A patent/AP3045A/xx active
- 2006-09-08 BR BRPI0603767-4A patent/BRPI0603767A/pt not_active Application Discontinuation
- 2006-09-08 CA CA2558764A patent/CA2558764C/fr not_active Expired - Fee Related
- 2006-09-08 TW TW095133157A patent/TWI369980B/zh not_active IP Right Cessation
- 2006-09-08 ES ES06291423T patent/ES2371482T3/es active Active
- 2006-09-08 NO NO20064049A patent/NO338079B1/no not_active IP Right Cessation
- 2006-09-08 SI SI200631105T patent/SI1762238T1/sl unknown
- 2006-09-08 DK DK06291423.9T patent/DK1762238T3/da active
- 2006-09-08 RS RS20110407A patent/RS52003B/en unknown
- 2006-09-08 PL PL06291423T patent/PL1762238T3/pl unknown
- 2006-09-08 PT PT06291423T patent/PT1762238E/pt unknown
- 2006-09-08 AU AU2006209371A patent/AU2006209371B2/en not_active Ceased
- 2006-09-08 GT GT200600410A patent/GT200600410A/es unknown
- 2006-09-08 AT AT06291423T patent/ATE519482T1/de active
- 2006-09-08 MX MXPA06010234A patent/MXPA06010234A/es active IP Right Grant
- 2006-09-11 JP JP2006245011A patent/JP2007077149A/ja active Pending
- 2006-09-11 KR KR1020060087623A patent/KR20070029607A/ko not_active Application Discontinuation
-
2009
- 2009-05-04 KR KR1020090038945A patent/KR20090056949A/ko not_active Application Discontinuation
-
2011
- 2011-09-08 CY CY20111100868T patent/CY1112223T1/el unknown
- 2011-10-14 HR HR20110749T patent/HRP20110749T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200722081A (en) | New therapeutic combinations for the treatment or prevention of depression | |
TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
TW200806300A (en) | New therapeutic combinations for the treatment of depression | |
TW200716120A (en) | Pyrazolo-pyrimidine derivatives as mGluR2 antagonists | |
TW200621262A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
TW200621777A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
UA86614C2 (ru) | Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата | |
ECSP066383A (es) | Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias | |
TW200621313A (en) | Pharmaceutical compositions | |
TW200738280A (en) | Novel pharmaceutical compositions comprising levetiracetam and process for their preparation | |
MX2012007273A (es) | Pteridinonas como inhibidores de la quinasa tipo polo. | |
ECSP088405A (es) | Nuevos derivados de pirimidina y su uso en terapia, así como el uso de derivados de pirimidina en la fabricación de un medicamento para la prevención y/o tratamiento de la enfermedad de alzheimer | |
CR10056A (es) | [(1h-indol-5-il)-heteroariloxi]-(1-aza-biciclo[3.3.1]nonanos como ligandos colinérgicos del n-achr para el tratamiento de trastornos piscóticos y neurodegenerativos | |
ME01456B (me) | Fumaratna so (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola | |
TW200740764A (en) | Pyrazolone derivatives | |
TW200616958A (en) | New alkyl-pyridines as 11-beta inhibitors for diabetes | |
AR054129A1 (es) | Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7 | |
MX2010001020A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas. | |
EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
EA201792597A3 (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
BRPI0816798A2 (pt) | composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação | |
SG179031A1 (en) | Hsl inhibitors useful in the treatment of diabetes | |
BR0311327A (pt) | Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo | |
GEP20084470B (en) | New phenylpyridinylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
TW200806321A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders |